Brian Lian - Jan 3, 2024 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
President & CEO, Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Jan 3, 2024
Transactions value $
-$4,469,612
Form type
4
Date filed
1/4/2024, 09:37 PM
Previous filing
May 1, 2023
Next filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Award $0 +150K +6.79% $0.00 2.36M Jan 3, 2024 Direct F1, F2
transaction VKTX Common Stock, par value $0.00001 per share Tax liability -$1.89M -109K -4.6% $17.40 2.25M Jan 3, 2024 Direct F3
transaction VKTX Common Stock, par value $0.00001 per share Award $0 +160K +7.11% $0.00 2.41M Jan 3, 2024 Direct F4
transaction VKTX Common Stock, par value $0.00001 per share Tax liability -$1.85M -106K -4.4% $17.40 2.3M Jan 3, 2024 Direct F5
transaction VKTX Common Stock, par value $0.00001 per share Tax liability -$735K -39.6K -1.72% $18.58 2.26M Jan 4, 2024 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Award $0 +360K $0.00 360K Jan 3, 2024 Common Stock 360K $17.40 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2022, 33.33% of which vested on January 3, 2024 upon the achievement of a non-financial performance goal.
F2 Includes 6,421 shares acquired on May 19, 2023 and 4,690 shares acquired on November 20, 2023 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
F3 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units.
F4 Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
F5 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.
F6 25% of the shares subject to the option will vest on each anniversary of the grant date.